| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 09/02/2004 | WO2004058999A3 Method and means for determining specific conditions or changes in the uterine epithelium and in the epithelium of other organs |
| 09/02/2004 | WO2004053076A3 Methods for rapid detection and identification of bioagents for environmental and product testing |
| 09/02/2004 | WO2004052285A3 Fat regulation |
| 09/02/2004 | WO2004046691A3 Uncaging devices |
| 09/02/2004 | WO2004045371A3 Methods for diagnosing the presence or stage of cancer |
| 09/02/2004 | WO2004038422A3 Inhibitors of src kinase for use in alzheimer's disease |
| 09/02/2004 | WO2004036224A3 Screening method |
| 09/02/2004 | WO2004033653A3 Gene regulation with aptamer and modulator complexes for gene therapy |
| 09/02/2004 | WO2004029296A3 Molecular size markers for species identification of mycobacteriae |
| 09/02/2004 | WO2004029288A3 Pcr-based diagnostic method of detecting a mutation in the b-raf gene |
| 09/02/2004 | WO2004026249A3 Methods and compositions for preventing skin damage |
| 09/02/2004 | WO2004024084A3 Rb pahtway and chromatin remodeling genes that antagonize let-60 ras signaling |
| 09/02/2004 | WO2004022702A3 Methods and reagents for identifying inhibitors of viral protease activity. |
| 09/02/2004 | WO2004020666A3 Diagnostic and therapeutic use of thyroid hormone binding protein for neurodegenerative diseases |
| 09/02/2004 | WO2004020665A3 Diagnostic and therapeutic use of foap-13 polynucleotides and polypeptides for neurodegenerative diseases |
| 09/02/2004 | WO2004018627A3 Methods for propagating adenovirus and virus produced thereby |
| 09/02/2004 | WO2004016765A3 Method for search based character optimization |
| 09/02/2004 | WO2004016212A3 Methods and compositions for targeting secretory lysosomes |
| 09/02/2004 | WO2004010101A3 Detection of chemical ligation using fluorescence quenching leaving groups |
| 09/02/2004 | WO2003085131A3 Diagnostic and therapeutic use of vault polynucleotides and proteins for neurodegenerative diseases |
| 09/02/2004 | WO2003083440A3 Methods and compositions for detection and quantitation of nucleic acid analytes |
| 09/02/2004 | WO2003080799A3 Polymorphic repetitive sequences in chlamydiae and uses thereof |
| 09/02/2004 | WO2003076932A3 Novel method for detecting and analyzing protein interactions in vivo |
| 09/02/2004 | WO2003072813A3 Single nucleotide polymorphisms predicting adverse drug reactions and medication efficacy |
| 09/02/2004 | WO2003070977A3 Method for detecting single nucleotide polymorphisms |
| 09/02/2004 | WO2003070967A3 Highly homogeneous molecular markers for electrophoresis |
| 09/02/2004 | WO2003016494A3 Diagnosis and treatment of vascular disease |
| 09/02/2004 | WO2003004689A3 Regulators of biofilm formation and uses thereof |
| 09/02/2004 | WO2002023185A3 Devices and methods for direct electronic readout of biomolecular interactions |
| 09/02/2004 | US20040172673 Expression vector comprising nucleotide sequences coding polypetide which confers resistance to pseudomonas syringae; genetic engineering and disease resistant plants |
| 09/02/2004 | US20040172669 Transgenic herbicide resistant sugarbeet with enhanced growth, yield, quality and pathogen resistance |
| 09/02/2004 | US20040171820 To be used in hybridization methods, for the determination of a nucleic acid |
| 09/02/2004 | US20040171811 for drug screening using animal models with in vitro activation; genetic engineering |
| 09/02/2004 | US20040171807 involves engineering a recombinant shuttle vector comprising a nucleic acid cassette encoding prokaryotic green fluorescent protein (GFP) operably linked to regulatory sequences which permit its expression in a host cell |
| 09/02/2004 | US20040171804 for drug screening cancer, osteoporosis, obesity, Alzheimer's disease drugs; genetic engineering; kits |
| 09/02/2004 | US20040171801 Nk-2 homeobox transcription factor |
| 09/02/2004 | US20040171689 Screening method using solid supports modified with self-assembled monolayers |
| 09/02/2004 | US20040171575 Antisense modulation of interferon gamma receptor 2 expression |
| 09/02/2004 | US20040171570 Polycyclic sugar surrogate-containing oligomeric compounds and compositions for use in gene modulation |
| 09/02/2004 | US20040171568 oligonucleotide at least 29 nucleotides in length, wherein the anti-HIV activity of said oligonucleotide occurs principally by a non-sequence complementary mode of action |
| 09/02/2004 | US20040171567 Method for detection of neoplastic cells |
| 09/02/2004 | US20040171559 stem cells require extracellular wnt signaling for proliferation and thus are rendered quiescent by administration of agents that block extracellular wnt signaling |
| 09/02/2004 | US20040171539 Regulation of human protein kinase-like protein |
| 09/02/2004 | US20040171538 Anticoagulants and their uses |
| 09/02/2004 | US20040171168 Inspection pretreatment method and inspection pretreatment system of bovine spongiform encephalopathy |
| 09/02/2004 | US20040171167 Chip-in-a-well scanning |
| 09/02/2004 | US20040171164 Method for measurement of immature granulocytes |
| 09/02/2004 | US20040171157 Recombinational cloning using nucleic acids having recombination sites |
| 09/02/2004 | US20040171156 for moving or exchanging segments of DNA molecules using proteins to provide chimeric DNA molecules in vitro and in vivo |
| 09/02/2004 | US20040171150 Antisense nucleotide sequences for prevention and treatment of sepsis, viral infection, autoimmune and cell proliferative disorders |
| 09/02/2004 | US20040171149 Oligonucleotides for controlling growth factor expression and treatment of cell proliferative and skin disorders; antisense agents |
| 09/02/2004 | US20040171137 Method and apparatus for detecting the presence of microbes and determining their physiological status |
| 09/02/2004 | US20040171122 Gm-csf and/or defensin protein expression regulators in epithelial cells comprising ets transcription factor or gene encoding the same |
| 09/02/2004 | US20040171111 Polypeptide of a p53 protein-specific murin a/t-cell receptor, nucleic acids coding therefor and use thereof |
| 09/02/2004 | US20040171110 Novel member of the lysyl oxidase gene family |
| 09/02/2004 | US20040171108 Human excitatory amino acid transporter-2 gene promoter and uses thereof |
| 09/02/2004 | US20040171105 Using enzymatic polypeptide to inactivate inhibitor of apoptosis and activate caspase for treatment and prevention of cancer, autoimmune and neurodegenerative diseases |
| 09/02/2004 | US20040171100 Method of detecting inorganic phosphoric acid, pyrophosphate and nucleic acid, and method of typing SNP sequence of DNA |
| 09/02/2004 | US20040171099 Using luciferin derivatives for analyzing metabolic activity in animals, cells or in cell-free reaction formulations |
| 09/02/2004 | US20040171098 Signalling compounds for use in methods of detecting hydrogen peroxide |
| 09/02/2004 | US20040171097 Method for determining the substrate specificity of an enzymatic activity and a device therefor |
| 09/02/2004 | US20040171096 Using lipid phosphates activity profile as diagnostic tool for detection and treatment of cancer; pregnancy determination; kits |
| 09/02/2004 | US20040171095 Using presence of prostaglandin D synthase (PGDS) in milk as indicator of mammary gland inflammation in milk cows; veterinary medicine |
| 09/02/2004 | US20040171090 Screening for cytotoxic t-lymphocyte recognition antigen associated with human t-cell leukemia virus infected cells for diagnosing and prognosing inflammation and cell proliferation disorders |
| 09/02/2004 | US20040171083 Polymorphisms of the 5' region of the human 5-HT1A gene, associated proteins of the 5' region and a diagnostic test for major depression and related mental illnesses |
| 09/02/2004 | US20040171080 Method of assaying for agonists or antagonist of dynorphin a binding to the mas receptor |
| 09/02/2004 | US20040171075 Modulation of protein functionalities |
| 09/02/2004 | US20040171061 Identifying modulators of lysosomal/reticuloendothelial system cell degradation for use in controlling/enhancing protein degradation/half-life |
| 09/02/2004 | US20040171060 Replicating and amplifying target nucleic acid sequence using polymerase, helicase and holliday structures; low temperature DNA amplification |
| 09/02/2004 | US20040171057 Electro-optical devices and methods for hybridization and detection |
| 09/02/2004 | US20040171056 Using peptide nucleic acids to identify genic variations which enhance gene therapeutic and/or drug treatments |
| 09/02/2004 | US20040171053 Solid support comprising microparticles with known addresses for use in analysis of gene expression, drug discovery and disease diagnostics |
| 09/02/2004 | US20040171052 Using intracellular expression of cytokines to prognosis outcomes of viral, cell proliferative and inflammatory diseases and/or drug therapies |
| 09/02/2004 | US20040171049 Methods and probes relating to Smith-Magenis syndrome and the RAI1 gene |
| 09/02/2004 | US20040171047 Using strand-displacement reverse transcription and rolling circle reverse transcription to detect and amplify preferential gene sequences |
| 09/02/2004 | US20040171046 Method for monitoring the transition of a cell from one state into another |
| 09/02/2004 | US20040171043 Thin filmed solid support comprising sulfated immobilized single-stranded nucleotide sequences for use in gene expression analysis; microarrays genomic patterning |
| 09/02/2004 | US20040171042 Functional assays that use theT1R1 receptor to screen for T1R1-associated taste modulators |
| 09/02/2004 | US20040171040 Detectable labeled nucleoside analogs and methods of use thereof |
| 09/02/2004 | US20040171039 Loop probe hybridization assay for polynucleotide analysis |
| 09/02/2004 | US20040171038 IL-1 gene cluster and associated inflammatory polymorphisms and haplotypes |
| 09/02/2004 | US20040171037 Using genic copy number of oncogenes to diagnose, prevent and treat tumor disorders; antitumor agents |
| 09/02/2004 | US20040171036 Levels of Pin1 in normal and cancerous tissue |
| 09/02/2004 | US20040171035 Methods and compositions for modulating P53 transcription factor |
| 09/02/2004 | US20040171034 for aiding in proteomic analysis wherein kinase and phosphatase substrates and enzymes can be identified; solid phase synthesis; kits |
| 09/02/2004 | US20040171033 Comprises modified nucleotide sequences for use in gene expression inhibition, viral defense, transposon silencing and treatment of metabolic disorders; antisense agents |
| 09/02/2004 | US20040171032 Non-phosphorous-linked oligomeric compounds and their use in gene modulation |
| 09/02/2004 | US20040171029 Comprises nucleotide sequences for use in gene expression inhibition, viral defense, transposon silencing and treatment of metabolic disorders; antisense agents |
| 09/02/2004 | US20040171028 Phosphorous-linked oligomeric compounds and their use in gene modulation |
| 09/02/2004 | US20040171027 Using mutation in acetolactate synthase gene to predict and screen for herbicide resistance in plants |
| 09/02/2004 | US20040171021 Diagnosing cell proliferative disorders via enhanced expression of migration inhibitory factor proteins; serum-based test for accurate detection and prognosis of tumor disorders |
| 09/02/2004 | US20040171019 Comprises nucleotide sequences coding isomerase which catalyzes rotation about proline residues for identifying modulators and designing treatments for cell proliferative disorders |
| 09/02/2004 | US20040171018 Mouse farnesoid x receptor sequences for use in comparative pharmacology |
| 09/02/2004 | US20040171016 Method of efficiently detecting double-stranded nucleic acid |
| 09/02/2004 | US20040171015 Cyp450-specific dna probes and primers, and biological applications thereof |
| 09/02/2004 | US20040171014 Quinacridone derivatives as labelling reagents for flurescence detection of bilogical materials |
| 09/02/2004 | US20040171012 Nucleic acid-associated proteins |
| 09/02/2004 | US20040171010 Methods |
| 09/02/2004 | US20040171008 G-protein coupled receptor arrays |
| 09/02/2004 | US20040171007 Using oligonuclleotide and DNA amplification to identify mycobacterium in biological samples; clinical diagnostics |